Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino A M
Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M University, Dallas 75246-0677, USA.
Cell Tissue Res. 1999 May;296(2):331-7. doi: 10.1007/s004410051293.
Diabetes (type I and type II) affects approximately 13 million people in the United States. Delayed and incomplete healing of wounds can be a major problem for diabetic patients. Macrophages are an important cell in the complex process of wound repair representing the major source of cytokines throughout the wound-healing process. Cytokines mediate many of the cellular responses critical to timely wound repair. It has been suggested that diabetes impairs wound healing through disruption of local cytokine production. Our previous in vivo studies in rats demonstrated that diabetes-induced and diet-induced hyperlipidemia cause changes in macrophage phenotype and function (Iacopino 1995; Doxey et al. 1998), suggesting that alterations in macrophage cytokine profiles represent the cellular/molecular mechanism responsible for delayed wound healing. The purpose of this study was to investigate how monocyte maturation/differentiation and cytokine production were altered by serum lipids in an in vitro system using human cells. Commercially prepared purified human monocytes were cultured and exposed to serum lipids. Phenotypic analysis of differentiated macrophages was then performed by flow cytometry and fluorescent microscopy using surface antigens specific for various macrophage subsets. Selected cytokines in conditioned medium were assayed using commercial human enzyme-linked immunosorbent assay (ELISA) kits. We demonstrate that serum lipids cause an increase in monocytic differentiation leading to an inflammatory macrophage phenotype rather than a reparative/proliferative phenotype. We also show that serum lipids cause a generalized decrease in macrophage cytokine production using interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), platelet-derived growth factor (PDGF), and transforming growth factor beta 1 (TGF-beta 1) as marker cytokines. Our present in vitro results using human cells confirm our previous in vivo studies in the rat and support the hypothesis that diabetes-induced hyperlipidemia alters the monocyte differentiation process resulting in changes of macrophage subsets and cytokine release at the wound site, ultimately impairing the wound-healing process.
糖尿病(I型和II型)在美国影响着约1300万人。伤口愈合延迟和不完全愈合对糖尿病患者来说可能是一个主要问题。巨噬细胞是伤口修复复杂过程中的重要细胞,在整个伤口愈合过程中是细胞因子的主要来源。细胞因子介导许多对及时伤口修复至关重要的细胞反应。有人提出糖尿病通过破坏局部细胞因子产生来损害伤口愈合。我们之前在大鼠身上进行的体内研究表明,糖尿病诱导和饮食诱导的高脂血症会导致巨噬细胞表型和功能发生变化(Iacopino,1995年;Doxey等人,1998年),这表明巨噬细胞细胞因子谱的改变代表了导致伤口愈合延迟的细胞/分子机制。本研究的目的是在使用人类细胞的体外系统中研究血清脂质如何改变单核细胞成熟/分化和细胞因子产生。将商业制备的纯化人类单核细胞进行培养并暴露于血清脂质中。然后通过流式细胞术和荧光显微镜使用针对各种巨噬细胞亚群的表面抗原对分化的巨噬细胞进行表型分析。使用商业人类酶联免疫吸附测定(ELISA)试剂盒检测条件培养基中选定的细胞因子。我们证明血清脂质会导致单核细胞分化增加,从而导致炎症性巨噬细胞表型而非修复/增殖性表型。我们还表明,以白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、血小板衍生生长因子(PDGF)和转化生长因子-β1(TGF-β1)作为标志物细胞因子,血清脂质会导致巨噬细胞细胞因子产生普遍减少。我们目前使用人类细胞的体外研究结果证实了我们之前在大鼠身上进行的体内研究,并支持以下假设:糖尿病诱导的高脂血症会改变单核细胞分化过程,导致伤口部位巨噬细胞亚群和细胞因子释放发生变化,最终损害伤口愈合过程。